You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 29, 2012

Tilleke & Gibbins Partners Discuss the Thai Pharmaceutical Industry

Focus Reports

The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies. In preparing a special report on the Thai pharmaceutical and healthcare sectors for Pharmaceutical Executive, Focus Reports asked Darani Vachanavuttivong, Tiziana Sucharitkul, and Alan Adcock, partners at Tilleke & Gibbins, to discuss challenges in these sectors, and how Tilleke & Gibbins is helping its pharmaceutical clients overcome such critical issues.

Pharmaceutical Executive is a monthly magazine for senior executives of leading pharmaceutical companies worldwide. Focus Reports is an independent publisher of country reports, focused on the pharmaceutical industry, and based on a wide range of analyses from interviews with government officials, manufacturers, leading multinational corporations, and experts.

The full Pharmaceutical Executive report on Thailand will be released in the weeks ahead. For a transcript of the Focus Reports interview, please click on the PDF below.

RELATED INSIGHTS​